| MATRIN3 Protein | |
|---|---|
| Protein Name | Matrin-3 |
| Encoded by | [MATRIN3](/genes/matrin3) |
| UniProt | [Q13148](https://www.uniprot.org/uniprotkb/Q13148/entry) |
| Localization | Nuclear matrix, nuclear speckles |
| Protein Class | RNA-binding protein, nuclear matrix structural constituent |
| Major Pathway | [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy), RNA processing |
MATRIN3 (Matrin-3) is a 846-amino acid nuclear matrix RNA-binding protein that plays critical roles in nuclear organization, RNA processing, and transcription regulation. Originally identified as a component of the nuclear matrix, MATRIN3 has emerged as a key player in neurodegenerative disease following the discovery that pathogenic mutations cause familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)[@johnson2014][@taylor2016].
MATRIN3 is a highly insoluble nuclear protein that forms part of the nuclear matrix scaffold, a structure that organizes the three-dimensional architecture of the nucleus and facilitates various nuclear processes including RNA transcription, processing, and transport. The protein contains multiple RNA recognition motifs (RRMs) and localizes to nuclear speckles where it colocalizes with other RNA-binding proteins involved in splicing, including TDP-43 and FUS[@bampton2019][@picher2017].
The identification of MATRIN3 mutations in ALS patients established a direct link between nuclear matrix dysfunction and motor neuron degeneration. Subsequent research has revealed that MATRIN3 pathology, including aggregates containing MATRIN3, is observed in multiple neurodegenerative diseases, making it a significant protein in understanding the pathogenesis of ALS-FTD spectrum disorders[@giordano2017][@gallego2021].
MATRIN3 contains several distinct functional domains that enable its diverse molecular functions:
N-terminal Domain (1-150 aa): Contains nuclear localization signals (NLS) and a serine-rich region with potential phosphorylation sites. This domain mediates interactions with nuclear envelope proteins and helps anchor MATRIN3 to the nuclear matrix[@sentandreu2017].
RNA Recognition Motifs (RRMs): MATRIN3 contains two RRM domains (RRM1: aa 180-250, RRM2: aa 320-390) that mediate RNA binding. These motifs are conserved across species and are essential for the protein's function in RNA processing[@picher2017].
Central Glycine-Rich Domain (aa 400-550): This low-complexity region contains multiple glycine residues and is implicated in protein-protein interactions. It shares similarity with other RNA-binding proteins that undergo liquid-liquid phase separation[@senden2018].
C-terminal Arginine-Rich Domain (aa 600-846): This region contains multiple arginine residues that facilitate interactions with nucleic acids and other RNA-binding proteins. It also contains a zinc finger-like motif that may contribute to RNA binding specificity[@malone2017].
MATRIN3 forms homodimers and higher-order oligomers through its central and C-terminal domains. This oligomerization is thought to be important for nuclear matrix anchoring and for the formation of nuclear protein aggregates observed in disease states. The protein can also interact with TDP-43, FUS, and other ALS-related proteins, suggesting that it may participate in the formation of stress granules and pathological inclusions[@heyer2017][@le2018].
MATRIN3 is a core component of the nuclear matrix, a proteinaceous scaffold that organizes the nucleus and provides structural support for various nuclear processes. The nuclear matrix is involved in:
Chromatin Organization: MATRIN3 helps anchor chromatin loops to the nuclear matrix, facilitating the formation of transcriptionally active compartments and silent chromatin domains[@coeffet2018].
DNA Replication: The nuclear matrix serves as a scaffold for DNA replication factories, and MATRIN3 may participate in the spatial organization of replication processes.
RNA Transcription and Processing: By anchoring transcription factors and RNA processing machinery to specific nuclear regions, MATRIN3 contributes to efficient gene expression[@martinez2019].
MATRIN3 participates in multiple aspects of RNA metabolism:
Alternative Splicing: MATRIN3 influences the splicing of specific target mRNAs, including transcripts encoding proteins involved in neuronal function and survival. Loss of MATRIN3 function leads to altered splicing patterns that may contribute to disease[@blokhuis2019].
RNA Stability: MATRIN3 can bind to specific mRNAs and regulate their stability, potentially protecting transcripts from degradation or facilitating their turnover.
Transcriptional Regulation: Through interactions with transcription factors and chromatin-modifying enzymes, MATRIN3 can influence gene expression at multiple levels[@coeffet2018].
Recent studies have revealed an unexpected role for MATRIN3 in maintaining genome stability:
DNA Repair: MATRIN3 localizes to sites of DNA damage and participates in the repair of double-strand breaks. Loss of MATRIN3 leads to increased genomic instability and sensitivity to DNA-damaging agents[@mark2015].
Telomere Maintenance: MATRIN3 has been implicated in telomere maintenance, suggesting additional roles in protecting chromosomal ends.
During neuronal development, MATRIN3 is highly expressed and contributes to:
Neuronal Differentiation: MATRIN3 regulates the expression of genes important for neuronal lineage commitment and maturation.
Synapse Formation: The protein localizes to synapses in mature neurons and may contribute to synaptic maintenance[@martinez2019].
MATRIN3 mutations cause disease primarily through loss-of-function mechanisms:
MATRIN3 mutations disrupt nuclear envelope integrity, leading to:
Nuclear Envelope Budding: Abnormal nuclear membrane structures form in cells expressing mutant MATRIN3, leading to nuclear envelope fragility[@sentandreu2017].
Nuclear Pore Complex Dysfunction: Altered MATRIN3 affects nuclear pore complex assembly and function, impairing nucleocytoplasmic transport.
Leakage of Nuclear Proteins: Nuclear envelope defects allow proteins like TDP-43 to leak into the cytoplasm, where they may form aggregates.
Loss of MATRIN3 function leads to:
Altered Splicing: Misregulation of ALS-related transcripts, including those involved in cytoskeletal function and mitochondrial maintenance[@blokhuis2019].
Impaired RNA Transport: Defects in dendritic RNA transport may contribute to synaptic dysfunction.
Stress Granule Dynamics: MATRIN3 deficiency affects stress granule formation and resolution, potentially contributing to proteostasis failure[@senden2018].
Mutant MATRIN3 disrupts nuclear matrix organization:
Chromatin Dysorganization: Altered nuclear matrix leads to changes in chromatin accessibility and gene expression.
Replication Stress: Impaired DNA replication capacity may contribute to neuronal vulnerability.
MATRIN3 pathology is observed in multiple neurodegenerative conditions:
ALS Motor Neurons: MATRIN3-positive inclusions are found in spinal motor neurons of sporadic ALS patients[@giordano2017].
FTD Brain Tissue: MATRIN3 aggregates are observed in frontotemporal cortex of FTD cases.
Co-aggregation with TDP-43: MATRIN3 frequently colocalizes with TDP-43 in pathological inclusions, suggesting shared mechanisms of aggregation[@le2018].
MATRIN3 interacts with several proteins implicated in ALS:
| Protein | Interaction Type | Functional Significance |
|---|---|---|
| TDP-43 (TARDBP) | Direct binding | Shared nuclear matrix localization, co-aggregation |
| FUS | Direct binding | RNA processing, stress granule formation |
| SMN Complex | Direct binding | RNA splicing machinery |
| hnRNPs | Indirect | RNA processing coordination |
MATRIN3 mutations account for approximately 1-2% of familial ALS cases:
Mutation Spectrum: Over 20 pathogenic mutations have been identified, including P154S, R195C, G298E, and others[@malone2017].
Phenotype: Patients with MATRIN3 mutations typically present with limb-onset ALS, with onset ages ranging from 30-70 years.
Disease Progression: MATRIN3-ALS generally follows a typical ALS progression, though some studies suggest a slightly slower disease course compared to other genetic subtypes[@ishihara2019].
Cognitive Involvement: A subset of MATRIN3 mutation carriers develop frontotemporal dementia, supporting the ALS-FTD continuum concept.
MATRIN3 is implicated in FTD pathogenesis:
Primary FTD: Some MATRIN3 mutations cause FTD without ALS, demonstrating phenotypic heterogeneity.
FTD Pathology: MATRIN3 inclusions are found in FTD brain tissue, often in association with TDP-43 pathology.
MATRIN3 pathology has been reported in:
In MATRIN3-related disease:
MATRIN3 testing is recommended for:
Key clinical features of MATRIN3-ALS: